Corticotropin therapy in myasthenia gravis: effects, indications, and limitations.
D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007362:Intensive Care Units; D009132:Muscles / Q000187:drug effects / Q000503:physiopathology; D009157:Myasthenia Gravis / Q000188:drug therapy* / Q000503:physiopathology; D013934:Thymectomy
D000324:Adrenocorticotropic Hormone